Annual Review of Cancer Biology

Papers
(The TQCC of Annual Review of Cancer Biology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer78
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo53
Immune Cell Metabolism and Immuno-Oncology31
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy26
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond26
Allogeneic CAR T Cell Therapy for Cancer25
Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer25
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division24
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?22
Road Map to Defeat Pancreatic Cancer21
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies20
Cancer Dependency Map: Past and Present20
Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches19
An Erratic Path Toward Discovery17
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance16
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy16
Engineering the Immune Microenvironment into Organoid Models14
Strategies for Heating Up Cold Tumors to Boost Immunotherapies14
Reinventing Radiobiology in the Light of FLASH Radiotherapy12
Extrachromosomal DNA: Biogenesis and Functions in Cancer11
Targeting Minimal Residual Disease11
RB1, Cancer Lineage Plasticity, and Therapeutic Resistance11
0.17891907691956